Cohance Lifesciences logo

Meet Cohance at
CPHI Milan 2026

APIs. Pellets. Formulations.

Reliable Generic Supplies. Scaled for Global Markets.

  • October 6-8, 2026
  • Fiera Milano, Milan, Italy
  • Stand #6C39

Cohance Lifesciences delivers Generic APIs and Finished Dosage Forms through an integrated API+ platform backed by strong chemistry expertise, global regulatory capabilities, and commercial manufacturing infrastructure.

Why Cohance

  • Integrated API + FDF Platform
  • Global Regulatory Approvals

Book a meeting

    Join us for our Stand Reception at Stand 6C39 on Day 2 of CPHI Milan 2026
    (Wednesday, 7 October | 5:00 PM–7:00 PM)

    RSVP:

    Your details are kept confidential and used only to respond to your request.
    0 +
    DMFs Filed Globally
    0 +
    Molecules Supported
    0 +
    Countries
    0
    API Manufacturing Facilities
    0
    FDF Manufacturing Facilities

    Small Molecule · HPAPI

    Generic APIs

    Deep Chemistry. Reliable Supply.

    Built on decades of chemistry expertise, our Generic API business supports customers across multiple therapeutic segments with a diversified portfolio, strong regulatory support, and dependable commercial supply.

    Capabilities

    • Commercial APIs
    • Controlled Substances
    • Oncology APIs
    • Intermediates
    • Backward-Integrated Supply Chain
    • Lifecycle Manufacturing Support

    Regulatory Strength

    • USDMFs
    • CEPs
    • EDMFs
    • KDMFs
    • ANVISA Filings
    • Global Regulatory Support

    ADC & XDC

    Pellets & Drug Delivery Solutions

    Proven Pellet Expertise for Global Markets.

    Our pellet platform supports modified-release and immediate-release products designed to meet diverse market requirements.

    Capabilities

    • Delayed Release Pellets
    • Modified Release Pellets
    • Immediate Release Pellets
    • DMF Supported Products
    • Technology Packages
    • Commercial Manufacturing

    Key Benefits

    • Faster Product Development
    • Proven Formulations
    • Commercial Scale Supply
    • Global Market Opportunities

    Nucleosides & Phosphoramidites Development and Manufacturing

    Finished Dosage Forms

    Development to Commercial Manufacturing.

    Our Finished Dosage Form platform helps customers accelerate access to quality medicines through integrated formulation and manufacturing solutions.

    Dosage Forms

    • Tablets
    • Capsules
    • Modified Release Products
    • Oral Liquids
    • Semisolids
    • Sachets
    • Topical Cloths

    Capacity Highlights

    • 3+ Billion Tablets Annually
    • 150+ Million Capsules Annually
    • 170 KL Liquid Capacity
    • 15 MT Semi-Solid Capacity
    • 20 Million Topical Cloths Annually

    Why Cohance FDF?

    • Integrated API + FDF Platform
    • Faster Time-to-Market
    • Commercial Manufacturing Expertise
    • Global Regulatory Support

    Learn More About Our Offerings

    Download the API brochure
    • Manufacturing Scale

    Built for Commercial Supply.

    Our manufacturing network is designed to support reliable, long-term supply across regulated and international markets.

    API Manufacturing Network

    • 7 cGMP Manufacturing Facilities
    • ~1400 KL Reactor Capacity
    • Multi-Site Supply Flexibility
    • Commercial Manufacturing Expertise

    R&D Strength

    • 2 Dedicated API R&D Centers
    • 150+ Scientists Focused on Generic APIs

    Global Regulatory Reach

    • USFDA
    • EDQM
    • PMDA
    • ANVISA
    • Health Canada
    • TGA
    • The Cohance API+ Advantage

    APIs + FDFs Under One Roof.

    Combining APIs and Finished Dosage Forms under a single platform helps customers:

    Reduce Supply Chain Complexity

    Improve Speed to Market

    Access Global Regulatory Expertise

    Strengthen Supply Reliability

    Simplify Partner Management

    Improve Commercial Execution

    Whether you are looking for a reliable API supplier, pellet development partner, or integrated API + formulation solution, Cohance provides the capabilities and scale needed to support your growth.

    • Let's Discuss

    Why Meet Cohance at CPHI Milan 2026?

    • Generic APIs
    • Controlled Substances
    • Oncology APIs
    • Pellets
    • Finished Dosage Forms
    • Commercial Manufacturing
    • Global Supply Partnerships
    • Portfolio Expansion Opportunities

    Ready to Expand Your Product Portfolio?

    Meet the Cohance API+ team at Stand #6C39 and explore how our integrated platform can support your sourcing, development, and manufacturing needs.

    Book a meeting

      Join us for our Stand Reception at Stand 6C39 on Day 2 of CPHI Milan 2026
      (Wednesday, 7 October | 5:00 PM–7:00 PM)

      RSVP:

      Your details are kept confidential and used only to respond to your request.

      Cohance Lifesciences logo

      Collaborate. Enhance. Deliver.

      Cohance Lifesciences Limited

      (Formerly, Suven Pharmaceuticals Limited)

      Meet us at CPHI Milan 2026
      Stand 6C39 · Hall 6
      6–8 October 2026
      Fiera Milano · Rho · Italy

      Book a meeting
      Linkedin Youtube